These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3262857)

  • 21. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
    Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjugated Haemophilus influenzae type b vaccine.
    Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
    Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
    Massó F; Paéz A; Arista A; Salmón L; Montaño L
    Arch Med Res; 1996; 27(4):539-45. PubMed ID: 8987192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemophilus influenzae type B vaccine in children with sickle cell disease: antibody persistence after vaccination at age one and one-half to six years.
    Marcinak JF; Frank AL; Labotka RL; Rao S; Frisone LR; Yogev R; McVerry P
    Pediatr Infect Dis J; 1991 Feb; 10(2):157-9. PubMed ID: 2062609
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants.
    Madore DV; Johnson CL; Phipps DC; Popejoy LA; Eby R; Smith DH
    Pediatrics; 1990 Mar; 85(3):331-7. PubMed ID: 2304786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
    Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
    J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Haemophilus influenzae vaccines].
    Bégué P
    Bull Acad Natl Med; 1993 Nov; 177(8):1381-7; discussion 1388-90. PubMed ID: 8193942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunogenicity and tolerability of Haemophilus b-tetanus protein conjugate (PRP-T) in children with sickle cell anemia].
    de Montalembert M; Bégué P; Fritzell B; Houmeau P
    Arch Fr Pediatr; 1993 Dec; 50(10):863-6. PubMed ID: 8053763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of Haemophilus influenzae type b vaccines.
    Stieb DM; Frayha HH; Oxman AD; Shannon HS; Hutchison BG; Crombie FS
    CMAJ; 1990 Apr; 142(7):719-33. PubMed ID: 2107962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
    Lepow ML; Samuelson JS; Gordon LK
    J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemophilus influenzae type b vaccine.
    Anderson P; Pichichero ME
    Pediatrics; 1989 Jan; 83(1):145-6. PubMed ID: 2909967
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age.
    Berkowitz CD; Ward JI; Meier K; Hendley JO; Brunell PA; Barkin RA; Zahradnik JM; Samuelson J; Gordon L
    J Pediatr; 1987 Apr; 110(4):509-14. PubMed ID: 3550021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
    Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR
    Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
    CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant.
    Anderson PW; Pichichero ME; Insel RA; Betts R; Eby R; Smith DH
    J Immunol; 1986 Aug; 137(4):1181-6. PubMed ID: 3016088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants.
    Lepow ML; Barkin RM; Berkowitz CD; Brunell PA; James D; Meier K; Ward J; Zahradnik JM; Samuelson J; McVerry PH
    J Infect Dis; 1987 Oct; 156(4):591-6. PubMed ID: 3497990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The PRP-D vaccination of Danish children. A study of immunogenicity of a Haemophilus influenzae type b vaccine coadministered with Di-Te-Pol to Danish children].
    Konradsen HB; Ejlertsen T; Henrichsen J
    Ugeskr Laeger; 1993 Sep; 155(37):2872-5. PubMed ID: 8259610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.